Evaluation of ctDNA in the Prediction of Response to Neoadjuvant Therapy and Prognosis in Locally Advanced Rectal Cancer Patients: A Prospective Study
“Watch and wait” is becoming a common treatment option for patients with locally advanced rectal cancer (LARC) submitted to neoadjuvant treatment. However, currently, no clinical modality has an acceptable accuracy for predicting pathological complete response (pCR). The aim of this study was to ass...
Main Authors: | Marina Morais, Telma Fonseca, Diogo Melo-Pinto, Isabel Prieto, Ana Teresa Vilares, Ana Luísa Duarte, Patrícia Leitão, Luís Cirnes, José Carlos Machado, Silvestre Carneiro |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/16/3/427 |
Similar Items
-
Evaluation of Response and Toxicity in Patients with Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiation
by: Balaji Shewalkar, et al.
Published: (2023-07-01) -
Biomarkers for Predicting the Response to Radiation-Based Neoadjuvant Therapy in Rectal Cancer
by: Yuhong Chen, et al.
Published: (2022-06-01) -
Identification of patients with locally advanced rectal cancer eligible for neoadjuvant chemotherapy alone: Results of a retrospective study
by: Yi‐min Han, et al.
Published: (2023-06-01) -
Identification of Blood-Based Biomarkers for the Prediction of the Response to Neoadjuvant Chemoradiation in Rectal Cancer
by: Delphine Dayde, et al.
Published: (2021-07-01) -
Utility of rectoscopy in the assessment of response to neoadjuvant treatment for locally advanced rectal cancer
by: Victor Lopez-Lopez, et al.
Published: (2016-01-01)